A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

NCT01413178 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

205

Enrollment

OTHER

Sponsor class

Conditions

Myeloma

Interventions

DRUG: Busulfan
DRUG: Melphalan
OTHER: Questionnaire
DRUG: G-CSF
DRUG: High Dose Melphalan
PROCEDURE: Stem cell transplant

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]